Aprea Therapeutics, Inc. (APRE)
SG&A Expense Growth
0.28%
Fiscal year · Period ending:
APRE SG&A Expense Growth
Latest reported0.28%period ending
Latest reported0.28%period ending
APRE FY SG&A Growth (YoY) (0.00% → 0.28%)
Latest values, visible window
High-resolution chart · PNG
APRE sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0.2765% | |
| -23.2993% | |
| -59.8439% | |
| 54.753% | |
| -9.2514% | |
| 77.2673% | |
| 267.0841% | |
| -6.711% | |
| 0% |